According to CBC News , Toronto internal medicine specialist and obesity researcher Sean Wharton says any blockbuster therapy attracts counterfeiters, but GLP1 drugs are on scale, a hundred times bigger than previous examples, and he points to a cultural desire for thinness and limited access for people who are not wealthy or well insured
Moreover, given that drug exposure is expected to be highest in the olfactory bulbs compared to other brain regions, IN chelator therapy may be particularly beneficial for disorders involving early olfactory bulb pathology or localized iron dysregulation near the nasal region (Deng et al., 2024)
GLP-1 medications are drugs that help control blood sugar and slow digestion
Herbert A, Wijlaars L, Zylbersztejn A, Cromwell D, Hardelid P